Abstract

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A Multicentre, Retrospective Observational Study to Evaluate the Clinical Outcomes of Patients with Chronic Lymphocytic Leukaemia (CLL) Treated with Idelalisib and Rituximab in the UK (RETRO-idel) - a Cohort of 110 Patients
Toby A Eyre ... Nishan Rajakumaraswamy
Blood | VOL. 134
Toby A Eyre, et. al.Toby A Eyre ... Nishan Rajakumaraswamy
13 Nov 2019
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia
David Oscier ... George Follows
British Journal of Haematology | VOL. 159
David Oscier, et. al.David Oscier ... George Follows
11 Oct 2012
PET Evaluation Before Autografting Has a Strong Prognostic Impact in High-Risk, Relapsed Follicular Lymphoma Patients
Loic Ysebaert ... Guy Laurent
Blood | VOL. 118
Loic Ysebaert, et. al.Loic Ysebaert ... Guy Laurent
18 Nov 2011
Baseline 18 F-FDG PET/CT May Portend the Prognosis of Patients With Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma After First-Line Treatment.
Qingqing Pan ... Xinxin Cao
Clinical nuclear medicine | VOL. 47
Qingqing Pan, et. al.Qingqing Pan ... Xinxin Cao
16 Aug 2022
View more papers

More From: Hematological oncology

Paper Title
Journal
Date
Author
From trials to statistical insights: Bortezomib's story in childhood T-cell lymphoid malignancies.
Shyam Srinivasan
Hematological oncology | VOL. 42
Shyam SrinivasanShyam Srinivasan
07 Aug 2024
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.
Evgenia Verrou ... Theodoros P Vassilakopoulos
Hematological oncology | VOL. 42
Evgenia Verrou, et. al.Evgenia Verrou ... Theodoros P Vassilakopoulos
06 Aug 2024
Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors-The MicroLinf Study.
Beatrice Casadei ... Pier Luigi Zinzani
Hematological oncology | VOL. 42
Beatrice Casadei, et. al.Beatrice Casadei ... Pier Luigi Zinzani
05 Aug 2024
Prognostic value of the "dynamic" R2-ISS in patients with multiple myeloma undergoing anti-CD38 antibody-based triplet therapies.
Taku Kikuchi ... Tadao Ishida
Hematological oncology | VOL. 42
Taku Kikuchi, et. al.Taku Kikuchi ... Tadao Ishida
03 Aug 2024
View more papers